Shopping Cart 0
Cart Subtotal
AED 0

Applied DNA Sciences Inc (APDN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company's products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA sequences, and identity markers, among others. Its supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, and mark, track, and convict criminals; and fiberTyping, a test of native cotton fiber DNA. The company serves government and military, security and asset marking, industrial parts, pharmaceuticals, cannabis, textiles and apparel, personal care, fertilizer, and printing and packaging industries. APDN is headquartered in Stony Brook, New York, the US.

Applied DNA Sciences Inc (APDN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Applied DNA Sciences Acquires Assets of Vandalia Research 11

Partnerships 12

ACG World to Enter into Agreement with Applied DNA Sciences 12

Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 13

Licensing Agreements 14

Colorcon Enters into Licensing Agreement with Applied DNA Sciences 14

Equity Offering 15

Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 15

Applied DNA Sciences Files Registration Statement to Raise USD11.3 Million in Public Offering of Shares upon Exercise of Warrants 16

Applied DNA Sciences Files Registration Statement to Raise USD5.4 Million in Private Placement of Shares upon Exercise of Warrants 17

Applied DNA Sciences to Raise USD1.8 Million in Private Placement of Shares 18

Applied DNA Sciences Raises USD5 Million in Private Placement of Shares and Warrants 19

Applied DNA Sciences Raises USD8.7 Million in Private Placement of Shares 20

Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 21

Applied DNA Sciences Raises USD9 Million in Public Offering of Shares and Warrants 23

Applied DNA Sciences Raises USD2.14 Million in Private Placement of Shares 25

Applied DNA Sciences Completes Private Placement Of Series B Preferred Stock For USD 5.5 Million 26

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 27

Applied DNA Sciences Completes Private Placement Of Series A Preferred Stock For USD 5.5 Million 28

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 29

Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 30

Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 31

Applied DNA Sciences Completes Private Placement Of Common Stock For USD 1.5 Million 32

Debt Offering 33

Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 33

Applied DNA Sciences Inc-Key Competitors 34

Applied DNA Sciences Inc-Key Employees 35

Applied DNA Sciences Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Strategy And Business Planning 37

Sep 18, 2018: Applied DNA forms wholly owned subsidiary, LineaRx, to develop large-scale, PCR-produced DNA for biotherapeutics 37

Financial Announcements 39

Aug 13, 2018: Applied DNA reports fiscal third quarter 2018 financial results 39

May 03, 2018: Applied DNA Reports Fiscal Second Quarter 2018 Financial Results 41

Feb 08, 2018: Applied DNA Reports Fiscal First Quarter 2018 Financial Results 43

Dec 28, 2017: Applied DNA Sciences Reports Year End and Fiscal Fourth Quarter Results 44

Dec 15, 2017: Applied DNA Announces Selected Preliminary Unaudited Fiscal Fourth Quarter and Year End Results 46

Dec 15, 2017: APDN Announces Selected Preliminary Unaudited Fiscal 4th Quarter and Year End Results 48

Aug 10, 2017: Applied DNA Reports Fiscal Third Quarter 2017 Financial Results 50

May 11, 2017: Applied DNA Sciences Reports Fiscal Second Quarter 2017 Financial Results 53

Feb 09, 2017: Applied DNA Sciences Reports Fiscal First Quarter 2017 Financial Results 55

Other Significant Developments 57

Oct 01, 2018: Linearx secures new RNA therapeutics customers for contract research services 57

Aug 02, 2018: Applied DNA Sciences reaches new milestones in therapeutic contract research and contract manufacturing of linear DNA 58

Oct 19, 2017: Applied DNA's SigNature Molecular Tag Technology Inducted into Material ConneXion's Innovation Library 59

Feb 14, 2017: APDN Builds Recurring Revenue in Synthetic Fiber Market with 3rd PO 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Applied DNA Sciences Acquires Assets of Vandalia Research 11

ACG World to Enter into Agreement with Applied DNA Sciences 12

Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 13

Colorcon Enters into Licensing Agreement with Applied DNA Sciences 14

Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 15

Applied DNA Sciences Files Registration Statement to Raise USD11.3 Million in Public Offering of Shares upon Exercise of Warrants 16

Applied DNA Sciences Files Registration Statement to Raise USD5.4 Million in Private Placement of Shares upon Exercise of Warrants 17

Applied DNA Sciences to Raise USD1.8 Million in Private Placement of Shares 18

Applied DNA Sciences Raises USD5 Million in Private Placement of Shares and Warrants 19

Applied DNA Sciences Raises USD8.7 Million in Private Placement of Shares 20

Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 21

Applied DNA Sciences Raises USD9 Million in Public Offering of Shares and Warrants 23

Applied DNA Sciences Raises USD2.14 Million in Private Placement of Shares 25

Applied DNA Sciences Completes Private Placement Of Series B Preferred Stock For USD 5.5 Million 26

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 27

Applied DNA Sciences Completes Private Placement Of Series A Preferred Stock For USD 5.5 Million 28

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 29

Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 30

Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 31

Applied DNA Sciences Completes Private Placement Of Common Stock For USD 1.5 Million 32

Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 33

Applied DNA Sciences Inc, Key Competitors 34

Applied DNA Sciences Inc, Key Employees 35

Applied DNA Sciences Inc, Subsidiaries 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Applied DNA Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company's products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA sequences, and identity markers, among others. Its supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, and mark, track, and convict criminals; and fiberTyping, a test of native cotton fiber DNA. The company serves government and military, security and asset marking, industrial parts, pharmaceuticals, cannabis, textiles and apparel, personal care, fertilizer, and printing and packaging industries. APDN is headquartered in Stony Brook, New York, the US.

Applied DNA Sciences Inc (APDN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Applied DNA Sciences Acquires Assets of Vandalia Research 11

Partnerships 12

ACG World to Enter into Agreement with Applied DNA Sciences 12

Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 13

Licensing Agreements 14

Colorcon Enters into Licensing Agreement with Applied DNA Sciences 14

Equity Offering 15

Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 15

Applied DNA Sciences Files Registration Statement to Raise USD11.3 Million in Public Offering of Shares upon Exercise of Warrants 16

Applied DNA Sciences Files Registration Statement to Raise USD5.4 Million in Private Placement of Shares upon Exercise of Warrants 17

Applied DNA Sciences to Raise USD1.8 Million in Private Placement of Shares 18

Applied DNA Sciences Raises USD5 Million in Private Placement of Shares and Warrants 19

Applied DNA Sciences Raises USD8.7 Million in Private Placement of Shares 20

Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 21

Applied DNA Sciences Raises USD9 Million in Public Offering of Shares and Warrants 23

Applied DNA Sciences Raises USD2.14 Million in Private Placement of Shares 25

Applied DNA Sciences Completes Private Placement Of Series B Preferred Stock For USD 5.5 Million 26

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 27

Applied DNA Sciences Completes Private Placement Of Series A Preferred Stock For USD 5.5 Million 28

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 29

Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 30

Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 31

Applied DNA Sciences Completes Private Placement Of Common Stock For USD 1.5 Million 32

Debt Offering 33

Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 33

Applied DNA Sciences Inc-Key Competitors 34

Applied DNA Sciences Inc-Key Employees 35

Applied DNA Sciences Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Strategy And Business Planning 37

Sep 18, 2018: Applied DNA forms wholly owned subsidiary, LineaRx, to develop large-scale, PCR-produced DNA for biotherapeutics 37

Financial Announcements 39

Aug 13, 2018: Applied DNA reports fiscal third quarter 2018 financial results 39

May 03, 2018: Applied DNA Reports Fiscal Second Quarter 2018 Financial Results 41

Feb 08, 2018: Applied DNA Reports Fiscal First Quarter 2018 Financial Results 43

Dec 28, 2017: Applied DNA Sciences Reports Year End and Fiscal Fourth Quarter Results 44

Dec 15, 2017: Applied DNA Announces Selected Preliminary Unaudited Fiscal Fourth Quarter and Year End Results 46

Dec 15, 2017: APDN Announces Selected Preliminary Unaudited Fiscal 4th Quarter and Year End Results 48

Aug 10, 2017: Applied DNA Reports Fiscal Third Quarter 2017 Financial Results 50

May 11, 2017: Applied DNA Sciences Reports Fiscal Second Quarter 2017 Financial Results 53

Feb 09, 2017: Applied DNA Sciences Reports Fiscal First Quarter 2017 Financial Results 55

Other Significant Developments 57

Oct 01, 2018: Linearx secures new RNA therapeutics customers for contract research services 57

Aug 02, 2018: Applied DNA Sciences reaches new milestones in therapeutic contract research and contract manufacturing of linear DNA 58

Oct 19, 2017: Applied DNA's SigNature Molecular Tag Technology Inducted into Material ConneXion's Innovation Library 59

Feb 14, 2017: APDN Builds Recurring Revenue in Synthetic Fiber Market with 3rd PO 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Applied DNA Sciences Acquires Assets of Vandalia Research 11

ACG World to Enter into Agreement with Applied DNA Sciences 12

Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 13

Colorcon Enters into Licensing Agreement with Applied DNA Sciences 14

Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 15

Applied DNA Sciences Files Registration Statement to Raise USD11.3 Million in Public Offering of Shares upon Exercise of Warrants 16

Applied DNA Sciences Files Registration Statement to Raise USD5.4 Million in Private Placement of Shares upon Exercise of Warrants 17

Applied DNA Sciences to Raise USD1.8 Million in Private Placement of Shares 18

Applied DNA Sciences Raises USD5 Million in Private Placement of Shares and Warrants 19

Applied DNA Sciences Raises USD8.7 Million in Private Placement of Shares 20

Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 21

Applied DNA Sciences Raises USD9 Million in Public Offering of Shares and Warrants 23

Applied DNA Sciences Raises USD2.14 Million in Private Placement of Shares 25

Applied DNA Sciences Completes Private Placement Of Series B Preferred Stock For USD 5.5 Million 26

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 27

Applied DNA Sciences Completes Private Placement Of Series A Preferred Stock For USD 5.5 Million 28

Applied DNA Sciences Completes Private Placement Of Shares For USD 2 Million 29

Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 30

Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 31

Applied DNA Sciences Completes Private Placement Of Common Stock For USD 1.5 Million 32

Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 33

Applied DNA Sciences Inc, Key Competitors 34

Applied DNA Sciences Inc, Key Employees 35

Applied DNA Sciences Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Applied DNA Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.